Navigation and Content
You are in  United Kingdom
or Select a different country


How to Secure Stable Supply Chains for Vaccines and Medical Goods During the COVID-19 Crisis and Future Health Emergencies

With countries across the world pinning their hopes on the efficient roll out of lifesaving vaccines in the fight against COVID-19, Governments, NGOs and medical-supplies companies are working at pace to ensure that their supply chain planning is resilient for this and future public-health emergencies.

Bringing medical supplies from their distant sources for use at the frontline was one of the most crucial activities in pandemic response management during the first phase of the COVID-19 health emergency.

White Paper Delivering Pandemic Resilience

With first emergency-use authorizations for COVID-19 vaccines expected in the last quarter of 2020, Governments, NGOs and medical-supplies companies will have to apply the lessons learnt during the pandemic so far, and prepare for the unprecedented challenge of providing global coverage during the next two years. The vital question is:

How can we secure stable supply chains for vaccines and other essential medical supplies during this and future public health emergencies?

White Paper is available in English, German, Spanish, French and Simplified Chinese.

In our white paper ‘Delivering Pandemic Resilience’, we’ve worked with McKinsey & Company as analytics partner, on finding answers to some of the big supply chain questions for countries facing large-scale public health emergencies.

We’ve also identified the challenges faced and lessons learned in the wake of the first phase of the COVID-19 pandemic, and particularly around inbound logistics and distribution.

Our white paper talks about the scale of the challenge as people prepare to leap the next hurdles of COVID-19 vaccine logistics. Our white paper talks about the scale of the challengeas people prepare to leap the next hurdles of COVID-19 vaccine logistics. What is the best way to organize the global supply chain to make sure vaccines arrive on time? And how can we cater for the needs of different geographical areas while ensuring sustainability in delivery and distribution.

Finally, we offer a framework for tackling future emergencies that covers robust emergency-response planning, the need for a strong partnership network, how to build the right logistics infrastructure and how to ensure your IT gives you high-level visibility over critical success factors such as stock levels.  

Download our white paper here and let’s start a conversation about how we can all work together – both public and private-sector organizations alike – so that our supply chains are fit enough to cope whatever the next, big public-health emergency throws at us.

You May Also Be Interested In

Post-Coronavirus Supply-Chain Recovery

In early 2020 and with little warning, the coronavirus began its onslaught on the world. Even in its early stage, the significant impact on supply chains and the crucial role of supply chain management became obvious. Many, if not all industries have been impacted in different ways, and times, and this has had a direct impact on the speed of recovery. Post-coronavirus, it seems inevitable that supply chains will be different: too much disruption has been caused; too many weaknesses exposed; too many lessons ruefully learned.

Life Sciences & Healthcare

The life sciences and healthcare sector is undergoing a period of intense transformation, as manufacturers, research bodies, hospitals and health professionals face increasing cost pressures, complexities and risks. You need to be equipped with agile, future-proofed solutions and the ability to navigate a multitude of challenges that include temperature control, cost efficiency, growth in the emerging markets and burgeoning new regulations.